UnitedHealth Group adds former CHOP CEO to board

UnitedHealth Group (UNH) plans to discontinue Medicare Advantage plans in 140 counties and exit Wyoming. The decision is based on historical data and analyst forecasts, according to Simply Wall St. The move may impact the company's market presence and investor perceptions.

UnitedHealth Group appointed Madeline S. Bell as an independent director on Nov. 3, 2026. Bell previously served as president and CEO of Children’s Hospital of Philadelphia. She has a background in pediatric nursing, hospital operations, and executive leadership, and has served on Comcast’s board.

UnitedHealth Group reported Q3 profit of $4.1B (up from $2.3B YoY) and revenue of $112.7B. CVS Health earned $2.2B (up from a $4B loss YoY) on $108.4B revenue, announcing a split of its pharmacy business. Cigna and Elevance Health each posted $1.4B profit. Centene reduced losses to $71M (from $6.6B YoY) on $50.6B revenue. Humana saw $162M profit (down from $195M) on $41.15B revenue, with positive Medicare enrollment trends.

UnitedHealth Group (UNH) appointed Madeline Bell as an independent director, effective November 3, 2026. She will be eligible for standard compensation and indemnification. Bell has not yet been assigned to any board committees.

Humana (HUM) gained 16.5% after its Medicare Advantage plan improved to four stars, restoring federal bonus eligibility. Analysts expect $4.8B in bonuses in 2028. UnitedHealth (UNH) and CVS (CVS) saw declines in four-star-plus plan memberships. Humana's 2027 EPS is projected to rebound to $17.31 after a 47% drop in 2026.

UnitedHealth Group's stock dropped 4% in after-hours trading, reducing its market value by $14 billion. The largest U.S. health insurer, with a market cap of $355.6 billion, saw significant decline, closing below the $400 threshold, which may influence near-term sentiment. The sell-off was gradual and sustained, indicating broad pressure.